Y-Intercept (HK)’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Y-Intercept (HK)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-302,995	Closed	-$9.13M	–	2159
2026 Q1	$9.13M	Buy	+302,995	New	+$9.75M	0.17%	129
2025 Q4	–	Sell	-111,196	Closed	-$2.25M	–	1980
2025 Q3	$2.25M	Buy	111,196 +98,520	+777%	+$1.73M	0.05%	550
2025 Q2	$212K	Sell	12,676 -180,711	-93%	-$2.92M	0.01%	1448
2025 Q1	$2.97M	Buy	193,387 +63,241	+49%	+$1.13M	0.2%	115
2024 Q4	$2.87M	Buy	+130,146	New	+$2.37M	0.19%	136
2024 Q3	–	Sell	-34,493	Closed	-$561K	–	1791
2024 Q2	$561K	Buy	+34,493	New	+$531K	0.03%	764
2023 Q3	–	Sell	-52,744	Closed	-$397K	–	1583
2023 Q2	$397K	Buy	+52,744	New	+$428K	0.04%	661
2023 Q1	–	Sell	-101,632	Closed	-$927K	–	1531
2022 Q4	$927K	Buy	+101,632	New	+$887K	0.14%	217
2022 Q2	–	Sell	-145,411	Closed	-$1.36M	–	1186
2022 Q1	$1.36M	Buy	+145,411	New	+$1.21M	0.31%	67
2021 Q4	–	Sell	-112,151	Closed	-$1.09M	–	876
2021 Q3	$1.09M	Buy	+112,151	New	+$1.05M	0.2%	166
2021 Q2	–	Sell	-13,649	Closed	-$155K	–	895
2021 Q1	$155K	Buy	+13,649	New	+$157K	0.04%	568

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Y-Intercept (HK)'s TEVA Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026, closing a stake of 302,995 shares — an estimated $9.13M sold.

Y-Intercept (HK) first reported a position in TEVA in Q1 2021 and held it in 11 quarters. The position peaked at $9.13M in Q1 2026. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Y-Intercept (HK) reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2026 after selling out during the quarter.
Y-Intercept (HK) sold 302,995 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $9.13M.
Y-Intercept (HK) first reported a position in Teva Pharmaceutical Industries Limited in Q1 2021 and held it in 11 quarters.
Y-Intercept (HK)'s Teva Pharmaceutical Industries Limited position peaked at $9.13M in Q1 2026.
676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.